Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400092053Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in sleep disorder (2 arms), sponsored by School of Stomatology, Fourth Military Medical University. Primary endpoint: Sleep disorder one day after surgery. Planned start Nov 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400092053.